Anxiety and Depression in Breast Cancer Patients Before and After Chemotherapy: A Pre–Post Study Without a Control Group
Open Access
- 16 November 2025
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (22) , 8105
Abstract
Background: Emotional disturbances such as anxiety and depression are common in breast cancer patients and may intensify during systemic therapy. This study aimed to assess changes in the severity of anxiety and depression among women undergoing neoadjuvant chemotherapy and to identify factors influencing emotional outcomes. Methods: A total of 211 women with stage I–III breast cancer treated at the Podkarpackie Oncology Center in Brzozów, Poland, were included. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS) one week before and three weeks after chemotherapy. Statistical analyses were performed using the Wilcoxon signed-rank test and descriptive statistics (STATISTICA v.13). Results: After chemotherapy, anxiety and depression levels increased significantly. Nearly half of the patients experienced clinically relevant anxiety, and over one-third showed symptoms of depression. The emotional burden appeared particularly high among women reporting financial difficulties. In contrast, no clear associations were found with marital status, place of residence, or cancer stage. Conclusions: Chemotherapy in breast cancer patients is associated with a significant increase in anxiety and depression severity. Routine psychological assessment and psycho-oncological support should be implemented as integral components of oncological care, with particular attention to patients in disadvantaged socioeconomic conditions.Keywords
Funding Information
- Ministry of Science and Higher Education of Poland under the statutory grant of the Wroclaw Medical University (SUBZ.E270.25.005)
This publication has 26 references indexed in Scilit:
- Physical and mental health of breast cancer patients and survivors before and during successive SARS-CoV-2-infection wavesQuality of Life Research, 2023
- Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical dataThe Lancet Psychiatry, 2014
- Cancer-related fatigue—mechanisms, risk factors, and treatmentsNature Reviews Clinical Oncology, 2014
- Prevalence of depression in cancer patients: a meta‐analysis of diagnostic interviews and self‐report instrumentsPsycho-Oncology, 2013
- Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and ageJournal of Affective Disorders, 2012
- Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trialsThe Lancet, 2012
- Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studiesThe Lancet Oncology, 2011
- Social support and survival in young women with breast carcinomaPsycho-Oncology, 2010
- Chemotherapy‐induced alopecia and effects on quality of life among women with breast cancer: a literature reviewPsycho-Oncology, 2007
- Influence of psychological response on survival in breast cancer: a population-based cohort studyThe Lancet, 1999